Skip navigation
Speakers

Endpoint Adjudication • Safety Assessment • Data Monitoring

November 6-7, 2018
  • Amsterdam, The Netherlands

Gerard Barron
Director, Clinical Operations
MedImmune (Philadelphia)

Sylvie Bartus, PhD
Director, Safety Officer, Global
Clinical Affairs, Heart Valve Therapy
Edwards Lifesciences

Kimberly Brown, RN
C5R CEC Manager, Research Programmes
Cleveland Clinic

Mads Engelmann, MD, PhD
International Medical Vice President
Novo Nordisk A/S (Denmark)

Eliezer Kats, MD, FACS
Senior Director, Clinical Development, RIA
MedImmune (Philadelphia)

Michal Konstacky, MD, PhD, MBA
Global Medical Director
Shire

Aisha Rashid
SMA Programme Lead
Biogen

Jonathan Seltzer, MD, MBA, MA, FACC
President
ACI Clinical

Ernest Spitzer, MD
Director of Clinical Endpoint Adjudication
Cardialysis

Dimitri Stamatiadis, PhD, MBA
Founder and Chief Executive Officer
MAIA Consulting

Catherine Tyner
Executive Director, Drug Safety and Adjudication Services
Covance

Beat Widler
Head of Quality Assurance, Managing Partner
Ethical GMBH

Gerard Barron
Director, Clinical Operations
MedImmune (Philadelphia)

Sylvie Bartus, PhD
Director, Safety Officer, Global
Clinical Affairs, Heart Valve Therapy
Edwards Lifesciences

Kimberly Brown, RN
C5R CEC Manager, Research Programmes
Cleveland Clinic

Mads Engelmann, MD, PhD
International Medical Vice President
Novo Nordisk A/S (Denmark)

Eliezer Kats, MD, FACS
Senior Director, Clinical Development, RIA
MedImmune (Philadelphia)

Michal Konstacky, MD, PhD, MBA
Global Medical Director
Shire

Aisha Rashid
SMA Programme Lead
Biogen

Jonathan Seltzer, MD, MBA, MA, FACC
President
ACI Clinical

Ernest Spitzer, MD
Director of Clinical Endpoint Adjudication
Cardialysis

Dimitri Stamatiadis, PhD, MBA
Founder and Chief Executive Officer
MAIA Consulting

Catherine Tyner
Executive Director, Drug Safety and Adjudication Services
Covance

Beat Widler
Head of Quality Assurance, Managing Partner
Ethical GMBH